ONEMEDNET CORPORATION Net Income (Loss) Available to Common Stockholders, Diluted
ONEMEDNET CORPORATION (ONMD) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$2.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-14
- ONEMEDNET CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$2.17M, a 178.52% decline year-over-year.
- ONEMEDNET CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was -$741.00K.
- ONEMEDNET CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2025-06-30 was $2.77M.
- ONEMEDNET CORPORATION net income (loss) available to common stockholders, diluted for the quarter ending 2024-09-30 was -$2.06M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|
| 2026-06-30 | -$2.17M 10-Q · filed 2026-08-14 | -$4.63M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$741.00K 10-Q · filed 2025-11-14 | $2.02M derived: sum of 2 quarters · filed 2026-08-14 | $305.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.77M 10-Q · filed 2026-08-14 | $1.00M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | -$2.06M 10-Q · filed 2025-11-14 | -$5.65M derived: sum of 2 quarters · filed 2025-11-14 | -$7.76M 10-Q · filed 2025-11-14 |
| 2024-06-30 | -$3.59M 10-Q · filed 2025-08-13 | -$5.70M 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |